IMMUNIZATION RECORD
Last
Name______________________________
First Name_________________________________ Date of Birth_____________
Address_________________________________ City__________________________
State_______________
Zip_____________
M.M.R. (Measles, Mumps, Rubella) 2
doses meets requirement
Dose #1_____/_____ Dose #2_____/_____
M Y M Y
Tetanus-Diphtheria (Primary series with DtaP
and booster with Td in the last ten years meet requirement.)
Dose #1_____/_____
Dose #2_____/_____ Dose
#3_____/_____ Dose #4_____/_____
M Y M Y M Y M Y
M Y
Polio (primary series in
childhood meets requirement); 3 primary
series schedules are acceptable.
1. OPV alone
(oral sabin 3 doses):
.#1 _____/_____
#2 _____/_____
#3_____/_____
M Y
M Y M Y
2.
IPV/OPV(sequential):
IPV #1 _____/_____ IPV#2 _____/_____ OPV #3 _____/_____ OPV #4 _____/_____
M Y M Y M Y M Y
3. IPV alone
(injected Salk 4 doses):
.. #1
_____/_____ #2 _____/_____ #3 _____/_____ #4 _____/_____
M Y M Y M Y M Y
Varicella (Either a history of
chicken pox, a positive Varicella antibody, or two doses of vaccine meets
recommendation.)
1. History of
Disease: Yes_____ No_____
2. Varicella
antibody _____/_____ Reactive_____ Non-reactive_____
M
Y
3.
Immunization
#1_____/_____
#2_____/_____
M Y M Y
Hepatitis B (3 doses of vaccine or two doses of adult vaccine in adolescents 11-15
years of age, or a positive Hepatitis B surface antibody meets recommendation.)
1. Immunization: #1_____/_____ #2 _____/_____ #3 _____/_____
M
Y M Y M Y
2. Hepatitis B surface antibody: _____/_____ Result:
Reactive _____ Non-reactive _____
M Y
1. Immunization:
#1 _____/_____ #2 _____/_____
M Y M Y
2. Immunization (combined Hepatitis A & B
Vaccine): #1 _____/_____ #2 _____/_____ #3 _____/_____
M Y M
Y M Y
Pneumococcal Polysaccharide
Vaccine (one dose
for members of high-risk groups recommended)
M Y
Influenza (Annual immunization
recommended)
_____/_____
_____/_____ _____/_____
_____/_____ _____/_____ _____/_____
_____/_____ _____/_____
M Y M Y M Y M Y M Y M Y M Y M Y
Meningococcal (First dose preferably at entry into college for freshmen living in
dormitories or residence halls who wish to reduce their risk of meningococcal
disease.) Any student who wishes to
reduce their risk of disease this vaccine is recommended. Repeat every 3-5 years. Meningococcal Vaccine may be purchased at:
Saline
1825 Atchinson Ave.
1.
Immunization: _____/_____ _____/_____
M Y M Y
NOTE: For any
student living on campus who does not wish to receive this vaccination, the
waiver below must be signed by the student or legal guardian if student is
under the age of 18 stating you understand the risks of meningitis disease
which can include: hearing loss, learning disability, brain damage, &
death.
Signature_____________________________________________
Tuberculosis Screening
1. Does the
student have signs or symptoms of tuberculosis disease? Yes_____
No_____
If no, proceed to 2.
If Yes, proceed with additional evaluation to exclude active
tuberculosis disease including tuberculin skin testing, chest x-ray and sputum
evaluation as indicated.
2. Is the
student a member of a high-risk group (populations in which TB is endemic) or
is the student entering the health profession?
Yes_____ No_____
If No, stop.
If Yes, place tuberculin skin test. (A history of BCG vaccination should
not preclude testing of a member of a high-risk group.)
3. Tuberculin
Skin Test: Date Given_____/_____ Date
Read_____/_____
Result:__________ (Record in mm of induration, if no
induration, write 0)
Interpretation (based on mm of induration as well as
risk factors): Positive_____ Negative_____
4. Chest x-ray (required if tuberculin skin test
is positive) Date of
x-ray_____/_____ Result Normal_____
Abnormal_____
The American College Health
Association has published guidelines on tuberculosis screening of college and
university students. These guidelines
are based on recommendations from the Centers For Disease Control and the
American Thoracic Society. For more
information, visit www.cdc.gov/nchstp/tb/pubs/corecurr/. The purpose of screening for tuberculosis
(TB) is to identify individuals with TB disease (active TB) or latent TB
infections (LTBI) manifested by a positive tuberculin skin test. Both TB disease and LTBI must be treated.
Health Care Provider
signature___________________________________________
Address___________________________________________ Phone_____________________